within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AX01_Nabumetone;

model Nabumetone
  extends Pharmacolibrary.Drugs.ATC.M.M01AX01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Nabumetone</td></tr><tr><td>ATC code:</td><td>M01AX01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Nabumetone is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of pain and inflammation in conditions such as osteoarthritis and rheumatoid arthritis. It is a prodrug that is converted in the liver to its active form, 6-methoxy-2-naphthylacetic acid (6-MNA). It is an approved medication still in use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adult volunteers after oral administration of nabumetone.</p><h4>References</h4><ol><li><p>Brier, ME, et al., &amp; Aronoff, GR (1995). Population pharmacokinetics of the active metabolite of nabumetone in renal dysfunction. <i>Clinical pharmacology and therapeutics</i> 57(6) 622â€“627. DOI:<a href=\"https://doi.org/10.1016/0009-9236(95)90224-4\">10.1016/0009-9236(95)90224-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7781261/\">https://pubmed.ncbi.nlm.nih.gov/7781261</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Nabumetone;
